PubMed Health⌕ Search

PubMed · 2665981

An approach to cutaneous changes caused by hematologic malignancies.

Abstract

Most hematologic malignancies can present with or later develop cutaneous lesions. The proper diagnosis of such patients through the evaluation of their cutaneous lesions is complicated both by the confusing variety of clinical findings and by the shifting classifications of hematologic malignancies in the face of evolving knowledge. The spectrum of T-cell malignancies continues to increase and now includes several disorders formerly attributed to B-cells or macrophages. The cutaneous findings of malignant and malignant behaving hematologic disorders are grouped by the presumed cellular etiology and by the clinical subset of tumor. Clinical and histopathologic features unique to individual disorders are emphasized, as well as those features that may be shared by otherwise quite dissimilar malignancies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W W Piette. 1989. An approach to cutaneous changes caused by hematologic malignancies.. https://pubmed.ncbi.nlm.nih.gov/2665981/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Occurrence of the yeast and filamentous fungi in haematological patients during 2002 to August 2005].

BACKGROUND: The number of diseases caused by yeast and fungi has been increasing recently. The primary disease is caused by dermatophytes and Cryptococcus neoformans. Other types of yeast and fungi can cause secondary infections of patients with predisposition factors. Among the mycotic diseases diagnosed in our laboratory can be included candidosis, cryptococcosis, aspergillosis and mucormycosis. METHODS AND RESULTS: In haematological patients Candida albicans, Candida glabrata, Candida krusei, Candida tropicalis and Saccharomyces cerevisiae are the most frequently diagnosed. CONCLUSIONS: Together with the increased number of examined samples, the rising number of strains resistant to azole antimycotics can be observed.

Hematologic Diseases↗